Examples of using Soliris in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
Low titre antibody responses have been detected in Soliris treated patients across all PNH
After 3 weeks of Soliris treatment, patients reported less fatigue
Soliris therapy must not be initiated without prior vaccination against Neisseria meningitidis at least 2 weeks prior to initial administration.
Special Handling and Storage Soliris vials must be stored in the original carton until time of use under refrigerated conditions at 2- 8ºC and protected from light.
Due to its mechanism of action, Soliris therapy should be administered with caution to patients with active systemic infections.
All patients must be vaccinated against meningococcus at least 2 weeks prior to receiving Soliris.
did not persist after the initial administration phase of Soliris.
In addition, the following adverse events were increased in frequency by 5% or more with Soliris as compared to placebo: nasopharyngitis(25.0%), nausea(17.1%), pyrexia(14.3%), myalgia(7.9%), fatigue(7.9%), and herpes simplex 5.7.
To reduce the risk of meningococcal infection(Neisseria meningitidis), all patients must be vaccinated at least 2 weeks prior to receiving Soliris and must be re-vaccinated according to current medical guidelines for vaccination use see section 4.4.
What is the risk associated with Soliris?
The side effects caused by Soliris are usually mild or moderate.
Breast-feeding Soliris may pass through your breast milk to your baby.
Soliris was administered as an intravenous infusion over 25- 45 minutes.
The effects of Soliris were compared with those of placebo a dummy treatment.
Infections Inform your doctor before you take Soliris if you have any infections.
Soliris is a concentrate that is made up into a solution for infusion.
Therefore, Soliris should be given to a pregnant woman only if clearly needed.
Administration of Soliris results in a rapid
Soliris(eculizumab) is indicated for the treatment of patients with paroxysmal nocturnal haemoglobinuria PNH.
Withdraw the total amount of Soliris from the vial(s) using a sterile syringe.